Characterisation of X chromosome status of human extended pluripotent stem cells
Cell Proliferation · 2023
DOI: 10.1111/cpr.13468 ↗At a glance
Journal article in Cell Proliferation, 2023. Written by Ying Wang and 11 co-authors. Institution: State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China. Major MEDLINE topics: Pluripotent Stem Cells, Human Embryonic Stem Cells. Cited 2 times so far (Crossref); 59 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Key Research and Development Program of China, Strategic Priority Research Program of the Chinese Academy of Sciences, Strategic Collaborative Research Program of the Ferring Institute of Reproductive Medicine, Ferring Pharmaceuticals, Chinese Academy of Sciences.
Abstract (original language)
Different pluripotent cell types have been established by capturing pluripotency in different states. Human extended pluripotent stem cells (hEPSCs), recently established by two independent studies, have the capability of differentiating into both embryonic and extraembryonic lineages, as well as forming human blastoids, showing great potential for early human development modeling and regenerative medicine. Considering that X chromosome status in female human pluripotent stem cells is dynamic and heterogeneous, and often leads to functional consequences, we characterized it in hEPSCs. We derived hEPSCs from primed human embryonic stem cells (hESCs) with defined X chromosome status (pre‐ or post‐X chromosome inactivation) using two previously published methods. We showed that hEPSCs derived using both methods had highly similar transcription profiles and X chromosome status. However, the X chromosome status of hEPSCs is largely determined by the primed hESCs from which they were derived, suggesting a lack of complete reprogramming of X chromosome during primed to extended/expanded pluripotency conversion. Furthermore, we found that the X chromosome status of hEPSCs affected their ability to differentiate into embryonic or extraembryonic lineage cells. Taken together, our work characterized the X chromosome status of hEPSCs, providing important information for the future application of hEPSCs.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
- University of Chinese Academy of Sciences, Beijing, China.
- Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China.
- Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.
- Department of Obstetrics and Gynaecology, Key Laboratory for Major Obstetric Diseases of Guangdong Province, Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, The Third Affiliated Hos…
ORCID profiles: Tang Hai, Guihai Feng, Haoyi Wang
Funding
- National Key Research and Development Program of China
- Strategic Priority Research Program of the Chinese Academy of Sciences
- Strategic Collaborative Research Program of the Ferring Institute of Reproductive Medicine, Ferring Pharmaceuticals, Chinese Academy of Sciences
Cite
APA
Wang, Y., Yang, N., Sun, W., Zhao, C., Hu, X., Lu, S., Cao, S., Wang, N., Hai, T., Feng, G., An, C., & Wang, H. (2023). Characterisation of X chromosome status of human extended pluripotent stem cells. Cell Proliferation. https://doi.org/10.1111/cpr.13468
Vancouver
Wang Y, Yang N, Sun W, Zhao C, Hu X, Lu S, et al. Characterisation of X chromosome status of human extended pluripotent stem cells. Cell Proliferation. 2023. doi:10.1111/cpr.13468
BibTeX
@article{Wang2023,
author = {Wang, Ying and Yang, Ning and Sun, Wen and Zhao, Chen and Hu, Xiaoxuan and Lu, Shan and Cao, Shiwei and Wang, Nannan and Hai, Tang and Feng, Guihai and An, Chenrui and Wang, Haoyi},
title = {Characterisation of X chromosome status of human extended pluripotent stem cells},
journal = {Cell Proliferation},
year = {2023},
doi = {10.1111/cpr.13468}
}
EUVIMED